Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology
Yale Cancer Center/Smilow Cancer HospitalGastrointestinal Cancers, Medical Oncology, Neuroendocrine
Dr. Kunz joins Yale from Stanford University School of Medicine where she was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. Beyond her record of accomplishment in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis. Education & Training: Oncology Fellow-Stanford University (2008) Chief Resident-Stanford University (2005) Internal Medicine Resident-Stanford University (2004) MD-Dartmouth Medical School (2001) BA-Dartmouth College, Biology (1994)
Professor
Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-ChampaignAdolescence, clinical psychologist, Coping, Depression, Developmental Psychology, Emotion Regulation, Family Relations, Gender, Interdisciplinary Research, neural processing, Neuroendocrine, Neuroscience, Peer Relationships, Psychopathology, Puberty, Teenagers
is a professor in the Department of Psychology at the University of Illinois Urbana-Champaign, a researcher at the Beckman Institute for Advanced Science and Technology and an affiliate at the Center for Social & Behavioral Science at Illinois.
The goal of Rudolph’s research is to identify risk and protective processes that amplify or attenuate vulnerability to psychopathology across development, with a focus on adolescence as a stage of particular sensitivity.
Her research uses an interdisciplinary, multi-level, multi-method approach that bridges across developmental and clinical psychology and social affective neuroscience. In particular, her research considers how personal attributes of youth (e.g., gender, temperament, emotion regulation, social motivation, coping, neuroendocrine profiles, neural processing), development (e.g., puberty, social transitions), and contexts (e.g., early adversity, stressors, family and peer relationships) intersect to contribute to the development of psychopathology, particularly depression and suicide. This research aims to understand both the origins and consequences of individual differences in risk.
Her lab uses a variety of methodological approaches, including longitudinal survey-based research, interviews, behavior observations, experimental tasks, hormone assessments and fMRI. Recent work also involves the development of a prevention program for adolescent depression.
Rudolph received her doctorate in clinical psychology at the University of California, Los Angeles, and completed a clinical internship at the Neuropsychiatric Institute and Hospital (now the Semel Institute for Neuroscience and Human Behavior) at UCLA before joining the faculty at Illinois. She served as co-editor of the "Handbook of Developmental Psychopathology" and an associate editor for the Journal of Clinical Child and Adolescent Psychology. She has served as a PI and co-PI on several large-scale longitudinal studies funded by the National Institutes of Health.